Stay updated on Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial
Sign up to get notified when there's something new on the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page.

Latest updates to the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has undergone significant content changes regarding the clinical trial for Gaucher Disease, including the removal of detailed trial descriptions and eligibility criteria, while a new revision number has been added.SummaryDifference22%
- Check69 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check112 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page.